argenx SE - SIC # 2830 -

Ticker Exchange SIC # Website Latest Ticker
ARGX Nasdaq 2830 argenx.com

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for argenx SE

argenx to Present at Upcoming Investor Conferences - Nov 2nd, 2026 11:00 pm
HALO Gears Up to Report Q3 Earnings: Is a Beat in the Cards? - Oct 30th, 2026 6:36 am
European Equities Traded in the US as American Depositary Receipts Rise in Thursday Trading - Oct 29th, 2026 9:36 am
argenx (ENXTBR:ARGX) Stock Looks Overvalued After Its 202% Five Year Run - Oct 24th, 2026 10:16 pm
argenx (ENXTBR:ARGX) Posted Q3 2026 Results, Is It Fully Priced? - Oct 24th, 2026 8:11 pm
argenx (ENXTBR:ARGX) Reports Positive Phase 3 Data In Autoimmune Myositis - Oct 24th, 2026 10:15 am
Argenx (ENXTBR:ARGX) Stock Faces Margin Questions After Q3 Earnings - Oct 24th, 2026 6:11 am
Argenx's Vyvgart Sales Growth, Pipeline Progress Support Outlook, Oppenheimer Says - Oct 23rd, 2026 11:00 am
Argenx's Vyvgart Beats Expectations With Focus Shifting to December Data, RBC Says - Oct 23rd, 2026 10:46 am
argenx: 3 Key Takeaways for Long-Term Investors - Oct 23rd, 2026 5:25 am
argenx (ARGX) Q3 2026 Earnings Call Transcript - Oct 23rd, 2026 2:42 am
Argenx Wavers After A Surprise Testing Setback For Its Bread-And-Butter Drug - Oct 22nd, 2026 2:25 pm
What argenex (ARGX) Said on Its Q3 Earnings Call - Oct 22nd, 2026 10:04 am
HRMY or ARGX: Which Is the Better Value Stock Right Now? - Oct 22nd, 2026 8:40 am
TD Cowen Names Top Biotech Stocks for Q4 Amid Market Volatility - Oct 22nd, 2026 7:34 am
Argenx slips as Q3 operating profit miss offsets Vyvgart sales beat - Oct 22nd, 2026 5:03 am
argenx Reports Third Quarter 2026 Financial Results and Provides Business Update - Oct 21st, 2026 11:00 pm
European Equities Traded in the US as American Depositary Receipts Advance in Tuesday Trading - Oct 20th, 2026 9:10 am
argenx to Present Phase 3 ALKIVIA Results in Autoimmune Myositis as a Late-Breaking Oral Presentation at ACR Convergence 2026 - Oct 19th, 2026 6:00 am